J&J Medical Connect
ICOTYDE™

(icotrokinra)

J&J Medical Connect

Connect with us

  • Products

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

ICOTYDE™ (icotrokinra)

Medical Information

ICOTYDE - Effect on Fertility

Last Updated: 03/18/2026

Summary

  • The company cannot recommend any practices, procedures or usage that deviate from the approved labeling.
  • Please refer to the local labeling for relevant information regarding effect of ICOTYDE on fertility.
  • The effect of ICOTYDE on human fertility has not been evaluated. Animal studies do not indicate direct or indirect harmful effects with respect to fertility.1

COMPANY CORE DATA SHEET

Animal Data

  • In male rats, icotrokinra had no effects on mating, fertility, or early embryonic development of their offspring at oral doses up to 20 mg/kg/day (114 times the maximum recommended human dose [MRHD] based on area under the curve [AUC] comparison).1 
  • In female rats, icotrokinra had no effects on estrous cyclicity, mating, fertility, or early embryonic parameters at oral doses up to 70 mg/kg/day (335 times the MRHD based on AUC comparison).1 

Literature Search

A literature search of MEDLINE®, EMBASE®, BIOSIS Previews®, and DERWENT® (and/or other resources, including internal/external databases) was conducted on 16 March 2026.

 

References

1 Data on File. Icotrokinra. Company Core Data Sheet v001. Janssen Research & Development, LLC. EDMS-RIM-1387700; 2025.